<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04144933</url>
  </required_header>
  <id_info>
    <org_study_id>BIO-625</org_study_id>
    <nct_id>NCT04144933</nct_id>
  </id_info>
  <brief_title>Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery</brief_title>
  <acronym>RUMBLE</acronym>
  <official_title>A Randomized Control Trial Evaluating the Utility of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Saskatchewan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Saskatchewan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine if an opioid-free general anesthetic (OFA)
      technique utilizing lidocaine, ketamine, dexmedetomidine and magnesium reduce postoperative
      opioid consumption and speed return of bowel function in patients undergoing elective,
      laparoscopic, colorectal surgery compared to traditional opioid-containing general anesthetic
      techniques. It is hypothesized that this intraoperative OFA regimen will reduce postoperative
      opioid consumption, and expedite return of bowel function in this population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this trial is to determine whether an opioid-free general anesthetic can
      help reduce postoperative opioid consumption and speed return of bowel function in patients
      undergoing elective, laparoscopic, colorectal surgery when compared with traditional
      opioid-containing techniques.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first flatus</measure>
    <time_frame>End of surgery to first flatus (1-4 days)</time_frame>
    <description>Time between the end of surgery and the movement when the patient first passes flatus</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to first defecation</measure>
    <time_frame>End of surgery to first defecation (1-7 days)</time_frame>
    <description>Time between the end of surgery and the moment the patient first passes stool</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to tolerance of oral intake</measure>
    <time_frame>End of surgery to first oral intake (1-3 days)</time_frame>
    <description>Time between the end of surgery to when the patient can tolerate any oral solid food intake</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Post-Anesthetic Care Unit (PACU) opioid consumption</measure>
    <time_frame>End of surgery to discharge from PACU (1-2 hours)</time_frame>
    <description>Total amount of opioid (morphine equivalents) required in PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Controlled Analgesia (PCA) morphine consumption</measure>
    <time_frame>End of surgery to 48 hours postoperatively</time_frame>
    <description>Total amount of PCA morphine (mg) required from end of surgery to 48 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Post-Anesthetic Care Unit (PACU) discharge readiness</measure>
    <time_frame>End of surgery to PACU discharge readiness (1-3 hours)</time_frame>
    <description>Time to Post-Anesthetic Care Unit (PACU) discharge readiness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) pain scores</measure>
    <time_frame>End of surgery to 48 hours postoperatively</time_frame>
    <description>Visual Analogue Scale (VAS) pain scores will be recorded on a scale of 0 to 10, with 0 indicating no pain, and 10 indicating extreme pain, 48 hours following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery after surgery</measure>
    <time_frame>End of surgery to time of patient discharge from hospital (2-10 days)</time_frame>
    <description>Assessed using the Quality of Recovery (QoR) 15 questionnaire, a validated tool for measuring quality of recovery after anesthesia and surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia</condition>
  <condition>General Anesthesia</condition>
  <condition>Analgesics, Opioid</condition>
  <condition>Opioid Free Anesthesia</condition>
  <condition>Postoperative Ileus</condition>
  <condition>Colorectal Surgery</condition>
  <condition>Laparoscopic Surgery</condition>
  <condition>Analgesia</condition>
  <condition>Dexmedetomidine</condition>
  <condition>Lidocaine</condition>
  <condition>Ketamine</condition>
  <arm_group>
    <arm_group_label>Opioid-free General Anesthesia (OFA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Opioid-free preoperative medications, Opioid-free pre-intubation medications, Opioid-free maintenance medication, postoperative nausea and vomiting prophylaxis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional Opioid-containing General Anesthesia (TOA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Opioid-sparing preoperative medications, Opioid-containing pre-intubation medications, Opioid-containing maintenance medications, postoperative nausea and vomiting prophylaxis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen, Gabapentin</intervention_name>
    <description>975 mg, 300 mg</description>
    <arm_group_label>Opioid-free General Anesthesia (OFA)</arm_group_label>
    <other_name>Opioid-free preoperative medications</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen, Gabapentin</intervention_name>
    <description>975 mg, 300 mg</description>
    <arm_group_label>Traditional Opioid-containing General Anesthesia (TOA)</arm_group_label>
    <other_name>Opioid-containing preoperative medications</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 1% Injectable Solution, Dexmedetomidine, Ketamine</intervention_name>
    <description>1.5 mg/kg, 0.5 mcg/kg, 0.5 mg/kg</description>
    <arm_group_label>Opioid-free General Anesthesia (OFA)</arm_group_label>
    <other_name>Opioid-free pre-intubation medications</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone, Ondansetron</intervention_name>
    <description>6 mg, 4 mg</description>
    <arm_group_label>Opioid-free General Anesthesia (OFA)</arm_group_label>
    <arm_group_label>Traditional Opioid-containing General Anesthesia (TOA)</arm_group_label>
    <other_name>Postoperative nausea and vomiting prophylaxis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane, Lidocaine 2% Injectable Solution, Ketamine, Dexmedetomidine, Magnesium Sulfate</intervention_name>
    <description>Dose titrated to effect, 1.5 mg/kg/hr, 0.15 mg/kg/hr, 0.3 -1 mcg/kg/hr (titrated to effect), 30 mg/kg bolus over 30 minutes</description>
    <arm_group_label>Opioid-free General Anesthesia (OFA)</arm_group_label>
    <other_name>Opioid-free maintenance medications</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine 1% Injectable Solution, Sufentanil</intervention_name>
    <description>0.5 mg/kg, 0.25-0.5 mcg/kg (titrated to effect)</description>
    <arm_group_label>Traditional Opioid-containing General Anesthesia (TOA)</arm_group_label>
    <other_name>Opioid-containing pre-intubation medications</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane, Sufentanil</intervention_name>
    <description>Dose titrated to effect, As needed (dose at anesthesiologist's discretion)</description>
    <arm_group_label>Traditional Opioid-containing General Anesthesia (TOA)</arm_group_label>
    <other_name>Opioid-containing maintenance medications</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18, American Society of Anesthesiology (ASA) class I-III patients scheduled for
             elective laparoscopic/laparoscopic assisted colorectal surgery

        Exclusion Criteria:

          -  Emergency surgery, open surgery, contraindications to laparoscopic surgery (ie.
             adhesions, inability to tolerate pneumoperitoneum), American Society of Anesthesiology
             (ASA) class 4, age &lt; 18, pregnant or breastfeeding women, significant
             cardiorespiratory/hepatic/renal disease, allergy to any study drugs, inability to
             consent, inability to respond to pain assessments, inability to use the patient
             controlled analgesia device (PCA)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jonathan Gamble, MD</last_name>
    <phone>306-655-1183</phone>
    <email>jonathan.gamble@saskhealthauthority.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal University Hospital</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 0W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Jennifer O'Brien, PhD</last_name>
      <phone>306-655-6497</phone>
      <email>jennifer.o'brien@saskatoonhealthregion.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 25, 2019</study_first_submitted>
  <study_first_submitted_qc>October 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>April 11, 2020</last_update_submitted>
  <last_update_submitted_qc>April 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Saskatchewan</investigator_affiliation>
    <investigator_full_name>Jonathan Gamble</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>Opioid-free</keyword>
  <keyword>Opioid-sparing</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

